When was TernaryTx founded?

TernaryTx was founded in 2024 and raised its 1st funding round 1 year after it was founded.

Where is TernaryTx located?

TernaryTx is headquartered in London, United Kingdom. It is registered at 115 Willian Road, Hitchin, SG4 0LT, England.

Who is the current CEO of TernaryTx?

Chris Tame of TernaryTx. They have also founded 1 company.

How many employees does TernaryTx have?

As of Jul 31, 2026, the latest employee count at TernaryTx is 17.

Is TernaryTx a funded company?

TernaryTx is a funded company, having raised a total of $4.76M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 27, 2025.

When was the latest funding round of TernaryTx?

TernaryTx's latest funding was a $***** Seed round on Mar 16, 2026, with participation from 4 investors.

Where does TernaryTx rank among its competitors?

TernaryTx ranks 1st amongst 10 active competitors, of which 4 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was LiteFold, which secured an undisclosed amount in May, 2026.

Who are the top competitors of TernaryTx?

TernaryTx's top competitors include Avilar, Epsilico and iN Therapeutics. Among them, LiteFold secured the most recent funding round in May, 2026.

TernaryTx - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of computational platform for molecular glue discovery and design. The platform identifies protein surface hotspots for ternary complex formation using proprietary models. It prioritizes virtual effector proteins, enabling mechanism deconvolution. The technology facilitates computational discovery of targetable binding sites using simulations. It also offers a glue-specific virtual screening platform using artificial intelligence methods.

Website: www.ternarytx.co.uk/
Email ID: *****@ternarytx.co.uk
Registered Address: 115 Willian Road, Hitchin, SG4 0LT, England

Key Metrics

Founded Year

2024

Location

London, United Kingdom

Stage

Seed

Total Funding

$4.76M in 2 rounds

Latest Funding Round

Seed, Mar 16, 2026, $*****

Investors

Daphni & 3 more

Ranked

1^st among 10 active competitors

Employee Count

17 as on Jul 31, 2026

Similar Companies

Avilar & 8 more

View TernaryTx's full profile

TernaryTx is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Ternary Therapeutics Ltd CIN: 16004737 , United Kingdom, Active	Oct 08, 2024	-	-

TernaryTx has raised a total funding of $4.76M over 2 rounds. Its first funding round was on Feb 27, 2025. Its latest funding round was a Seed round on Mar 16, 2026 for $*****. 4 investors participated in its latest round. TernaryTx has 4 institutional investors.

Here is the list of recent funding rounds of TernaryTx:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 16, 2026	7120873	Seed	5237369	3529288	6561843	9905766
Feb 27, 2025	1961313	Seed	2760957	9388640	Pace Ventures	i&i Bio

Access funding benchmarks and valuations. Sign up today!

View details of TernaryTx's funding rounds and investors

The founders of TernaryTx are Andrew Potterton and Chris Tame. Chris Tame is the CEO of TernaryTx.

Here are the details of TernaryTx's key team members:

Andrew Potterton: Co-Founder & CTO of TernaryTx.
Contact Info: 1 email address
Chris Tame: Co-Founder & CEO of TernaryTx.
Contact Info: 1 email address

View details of TernaryTx's Founder profiles and Board Members

TernaryTx's employee count trend

TernaryTx has 17 employees as of Jul 26. Here is TernaryTx's employee count trend over the years:

Uncover TernaryTx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TernaryTx include Avilar, Epsilico and iN Therapeutics. Here is the list of Top 10 competitors of TernaryTx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TernaryTx 2024, London (United Kingdom), Seed	Developer of computational platform for molecular glue discovery and design	$4.76M	Daphni, Future Planet Capital & 2 others	42/100
2nd	Avilar 2020, Waltham (United States), Seed	Provider of drug discovery platform and protein degradation technology	$75.3M	Sanofi Ventures, Astellas Venture Management ... & 2 others	40/100
3rd	Epsilico 2020, Berlin (Germany), Seed	Generative AI technology for designing biologics	-	Life Science Valley, Europa & 1 others	36/100
4th	iN Therapeutics 2020, Yongin (South Korea), Funding Raised	Developer of drugs for patients with rare neurological diseases	-	E&Venture Partners, Korea Omega Investment Corp	32/100
5th	LiteFold 2025, Dover (United States), Seed	AI platform focused on accelerating protein engineering and drug discovery workflows	-	3F VC, Mercatus	30/100
6th	Levitate Bio 2024, Kirkland (United States), Unfunded	Platform offering automated and customized AI solutions for biopharma drug discovery	-	-	26/100
7th	Interdict 2022, San Francisco (United States), Funding Raised	Developer of a small molecule therapeutics platform to address undruggable targets	-	Altitude Life Science Ventures	24/100
8th	Ubiquitx 2021, Cambridge (United States), Funding Raised	Developer of AI-powered platform for targeted protein degradation therapeutics design	-	E14 Fund, HHS	22/100
9th	FuturedMe 2018, Tokyo (Japan), Funding Raised	Developer of platform for protein degradation for development of small molecule based drug	-	JAFCO Group	22/100
10th	Adhesion Therapeutics 2024, Graz (Austria), Funding Raised	AI-enabled molecular glue degraders aimed at treating diseases	-	Europa	15/100